DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models
Yuki Kagoya(Aichi Cancer Center), Naoto Hirano(Ontario Institute for Cancer Research)
Cited by 29
Related Papers
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity
|Journal of Clinical Investigation|2014|216
BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models
|Journal of Clinical Investigation|2016|214
HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway
|Nature Communications|2017|40
Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells
|Cell Reports Medicine|2024|20